No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d2j31A1, 1.0000, 0.00, 1.000, 239, 239, THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND ACTIVITY OF(PRO)CASPASE-3
2, p5i9bA_, 0.9990, 0.18, 0.992, 240, 239, CASPASE 3 V266A
3, p4qu8A_, 0.9990, 0.18, 0.987, 240, 239, CASPASE-3 M61A V266H
4, p5ibpA_, 0.9989, 0.19, 0.992, 240, 239, CASPASE 3 V266M
5, d2j32A1, 0.9989, 0.18, 0.992, 239, 239, THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND ACTIVITY OF(PRO)CASPASE-3
6, d2j30A1, 0.9989, 0.18, 0.996, 244, 239, THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND ACTIVITY OF (PRO)CASPASE-3
7, p5iarA_, 0.9988, 0.20, 0.992, 240, 239, CASPASE 3 V266W
8, p5iaeC_, 0.9988, 0.20, 0.992, 241, 239, CASPASE 3 V266F
9, p5iaeA_, 0.9988, 0.19, 0.992, 241, 239, CASPASE 3 V266F
10, p4ehfA_, 0.9987, 0.20, 0.987, 242, 239, ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS
11, p4ehdA_, 0.9987, 0.20, 0.992, 239, 239, ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS
12, d3pcxA1, 0.9987, 0.20, 0.987, 243, 239, CASPASE-3 E246A K242A DOUBLE MUTANT
13, d3itnA1, 0.9987, 0.21, 0.992, 239, 239, CRYSTAL STRUCTURE OF PSEUDO-ACTIVATED PROCASPASE-3
14, p5ibcA_, 0.9986, 0.21, 0.992, 241, 239, CASPASE 3 V266I
15, d4qtyA1, 0.9986, 0.21, 0.992, 239, 239, CASPASE-3 E190A
16, p4pryA_, 0.9986, 0.21, 0.996, 249, 239, CASPASE-8 SPECIFIC UNNATURAL AMINO ACID PEPTIDES
17, p5iagA_, 0.9985, 0.22, 0.992, 239, 239, CASPASE 3 V266Q
18, d4jjeA1, 0.9985, 0.22, 0.996, 239, 239, CASPASE-3 SPECIFIC UNNATURAL AMINO ACID PEPTIDES
19, p5iasA_, 0.9984, 0.23, 0.992, 240, 239, CASPASE 3 V266Y
20, p4qujA_, 0.9984, 0.23, 0.987, 240, 239, CASPASE-3 T140GV266H
21, p4quiA_, 0.9984, 0.23, 0.987, 248, 239, CASPASE-3 F128AV266H
22, p4qu0A_, 0.9982, 0.24, 0.987, 240, 239, CASPASE-3 Y195AV266H
23, p4quaA_, 0.9966, 0.44, 0.992, 240, 239, CASPASE-3 Y195F
24, p5iakA_, 0.9964, 0.47, 0.992, 240, 239, CASPASE 3 V266S
25, p4qu5A_, 0.9964, 0.45, 0.992, 240, 239, CASPASE-3 T140V
26, p5ianA_, 0.9957, 0.47, 0.992, 240, 239, CASPASE 3 V266N
27, p5i9tA_, 0.9949, 0.17, 0.992, 239, 238, CASPASE 3 V266C
28, p4qu9A_, 0.9947, 0.18, 0.992, 240, 238, CASPASE-3 F128A
29, p4qubA_, 0.9946, 0.20, 0.992, 240, 238, CASPASE-3 K137A
30, p4quiB_, 0.9945, 0.21, 0.987, 248, 238, CASPASE-3 F128AV266H
31, d1nme.1, 0.9932, 0.29, 0.992, 238, 238, STRUCTURE OF CASP-3 WITH TETHERED SALICYLATE
32, p5i9tC_, 0.9927, 0.42, 0.992, 239, 238, CASPASE 3 V266C
33, d1gfw.1, 0.9915, 0.38, 0.992, 238, 238, THE 2.8 ANGSTROM CRYSTAL STRUCTURE OF CASPASE-3 (APOPAIN OR CPP32)IN COMPLEX WITH AN ISATIN SULFONAMIDE INHIBITOR.
34, d3pd0A1, 0.9906, 0.18, 0.987, 237, 237, CASPASE-3 E246A
35, d3pd1A1, 0.9905, 0.19, 0.992, 237, 237, CASPASE-3 K242A
36, p4qtxA_, 0.9898, 0.24, 0.992, 237, 237, CASPASE-3 Y195A
37, p4qudA_, 0.9885, 0.57, 0.992, 238, 238, CASPASE-3 T140F
38, p4ehhA_, 0.9820, 0.21, 0.991, 235, 235, ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS
39, d1nmqB_, 0.9771, 0.25, 0.991, 238, 234, EXTENDEND TETHERING: IN SITU ASSEMBLY OF INHIBITORS
40, d1nmqA_, 0.9771, 0.26, 0.991, 238, 234, EXTENDEND TETHERING: IN SITU ASSEMBLY OF INHIBITORS
41, p4ps0A_, 0.9769, 0.27, 0.996, 244, 234, CASPASE-8 SPECIFIC UNNATURAL AMINO ACID PEPTIDES
42, p4qulC_, 0.9764, 0.30, 0.991, 235, 234, CASPASE-3 F55W
43, d1i3o.1, 0.9754, 0.57, 0.991, 244, 235, CRYSTAL STRUCTURE OF THE COMPLEX OF XIAP-BIR2 AND CASPASE 3
44, p5iajA_, 0.9753, 0.47, 0.991, 235, 234, CASPASE 3 V266L
45, d1i3o.2, 0.9750, 0.58, 0.991, 245, 235, CRYSTAL STRUCTURE OF THE COMPLEX OF XIAP-BIR2 AND CASPASE 3
46, d1nmsA_, 0.9747, 0.39, 0.991, 240, 234, CASPASE-3 TETHERED TO IRREVERSIBLE INHIBITOR
47, p5iabA_, 0.9746, 0.39, 0.991, 235, 234, CASPASE 3 V266D
48, d1nmsB_, 0.9743, 0.41, 0.991, 240, 234, CASPASE-3 TETHERED TO IRREVERSIBLE INHIBITOR
49, p4ehnA_, 0.9737, 0.20, 0.983, 233, 233, ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS
50, d2j33A1, 0.9737, 0.20, 0.991, 233, 233, THE ROLE OF LOOP BUNDLE HYDROGEN BONDS IN THE MATURATION AND ACTIVITY OF (PRO)CASPASE-3
51, p4fdlB_, 0.9732, 0.84, 0.564, 239, 236, CRYSTAL STRUCTURE OF CASPASE-7
52, p4ps0B_, 0.9729, 0.26, 0.996, 237, 233, CASPASE-8 SPECIFIC UNNATURAL AMINO ACID PEPTIDES
53, p4quhC_, 0.9727, 0.27, 0.991, 234, 233, CASPASE-3 T140G
54, p4ehkC_, 0.9721, 0.30, 0.987, 233, 233, ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS
55, p4queA_, 0.9718, 0.36, 0.983, 234, 233, CASPASE-3 Y195FV266H
56, d3dekB_, 0.9718, 0.32, 0.991, 234, 233, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
57, p4quhA_, 0.9713, 0.35, 0.991, 233, 233, CASPASE-3 T140G
58, d3h0eB_, 0.9713, 0.35, 0.996, 238, 233, 34-DIHYDROPYRIMIDO(12-A)INDOL-10(2H)-ONES AS POTENT NON- PEPTIDIC INHIBITORS OF CASPASE-3
59, p5jftA_, 0.9711, 0.71, 0.621, 238, 235, ZEBRA FISH CASPASE-3
60, p5iabC_, 0.9711, 0.43, 0.991, 234, 233, CASPASE 3 V266D
61, d3dejB_, 0.9711, 0.36, 0.991, 234, 233, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
62, d3dehB_, 0.9711, 0.36, 0.991, 234, 233, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
63, p4qugA_, 0.9690, 0.24, 0.991, 232, 232, CASPASE-3 M61A
64, p4queC_, 0.9684, 0.28, 0.987, 232, 232, CASPASE-3 Y195FV266H
65, d3deiD_, 0.9683, 0.48, 0.991, 233, 233, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
66, p5jftB_, 0.9680, 0.64, 0.624, 235, 234, ZEBRA FISH CASPASE-3
67, p4ehaA_, 0.9678, 0.31, 0.991, 232, 232, ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS
68, d1qx3A_, 0.9678, 0.31, 0.991, 232, 232, CONFORMATIONAL RESTRICTIONS IN THE ACTIVE SITE OF UNLIGANDED HUMAN CASPASE-3
69, p4qugC_, 0.9674, 0.34, 0.991, 232, 232, CASPASE-3 M61A
70, d3deiB_, 0.9672, 0.34, 0.991, 232, 232, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
71, p4ehkA_, 0.9669, 0.44, 0.987, 233, 232, ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS
72, p4ehaC_, 0.9669, 0.36, 0.991, 232, 232, ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS
73, d3dekC_, 0.9666, 0.55, 0.991, 234, 233, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
74, d3h0eA_, 0.9664, 0.38, 0.996, 237, 232, 34-DIHYDROPYRIMIDO(12-A)INDOL-10(2H)-ONES AS POTENT NON- PEPTIDIC INHIBITORS OF CASPASE-3
75, p4ehlC_, 0.9661, 0.48, 0.987, 232, 232, ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS
76, d1cp3A_, 0.9661, 0.40, 0.991, 232, 232, CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE TETRAPEPTIDE INHIBITOR ACE-DVAD-FMC
77, d3deiC_, 0.9659, 0.57, 0.991, 233, 233, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
78, d1cp3B_, 0.9657, 0.42, 0.991, 232, 232, CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE TETRAPEPTIDE INHIBITOR ACE-DVAD-FMC
79, d3dekA_, 0.9652, 0.44, 0.991, 232, 232, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
80, d3dejA_, 0.9645, 0.47, 0.991, 232, 232, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
81, d3dehA_, 0.9645, 0.47, 0.991, 232, 232, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
82, d1rhk.1, 0.9644, 0.27, 0.996, 231, 231, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A PHENYL-PROPYL- KETONE INHIBITOR
83, d1re1.1, 0.9644, 0.27, 0.996, 231, 231, CRYSTAL STRUCTURE OF CASPASE-3 WITH A NICOTINIC ACID ALDEHYDE INHIBITOR
84, d3dekD_, 0.9642, 0.48, 0.991, 232, 232, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
85, d1rhj.1, 0.9641, 0.28, 0.996, 231, 231, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A PRYAZINONE INHIBITOR
86, d1pau.1, 0.9640, 0.29, 0.996, 231, 231, CRYSTAL STRUCTURE OF THE COMPLEX OF APOPAIN WITH THE TETRAPEPTIDE ALDEHYDE INHIBITOR AC-DEVD-CHO
87, p3r5kB_, 0.9638, 0.62, 0.567, 237, 233, A DESIGNED REDOX-CONTROLLED CASPASE-7
88, d1rhj.2, 0.9635, 0.32, 0.996, 231, 231, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A PRYAZINONE INHIBITOR
89, d1i4oA_, 0.9629, 1.13, 0.566, 235, 235, CRYSTAL STRUCTURE OF THE XIAP/CASPASE-7 COMPLEX
90, d3dehC_, 0.9626, 0.54, 0.991, 232, 232, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
91, p4ehlA_, 0.9624, 0.45, 0.987, 231, 231, ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS
92, p3r5kA_, 0.9624, 0.66, 0.567, 234, 233, A DESIGNED REDOX-CONTROLLED CASPASE-7
93, d3dejC_, 0.9621, 0.56, 0.991, 232, 232, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
94, d1rhm.1, 0.9621, 0.39, 0.996, 231, 231, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A NICOTINIC ACID ALDEHYDE INHIBITOR
95, d4jr2B1, 0.9620, 0.55, 0.573, 232, 232, HUMAN PROCASPASE-7/CASPASE-7 HETERODIMER BOUND TO AC-DEVD-CMK
96, d1rhm.2, 0.9614, 0.42, 0.996, 231, 231, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A NICOTINIC ACID ALDEHYDE INHIBITOR
97, d1kmcA_, 0.9614, 0.73, 0.567, 234, 233, CRYSTAL STRUCTURE OF THE CASPASE-7 / XIAP-BIR2 COMPLEX
98, p3h1pB_, 0.9607, 0.59, 0.565, 233, 232, MATURE CASPASE-7 I213A WITH DEVD-CHO INHIBITOR BOUND TO ACTIVE SITE
99, d1rhu.1, 0.9606, 0.45, 0.996, 231, 231, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A 567 TRICYCLIC PEPTIDOMIMETIC INHIBITOR
100, p3h1pA_, 0.9605, 0.60, 0.565, 232, 232, MATURE CASPASE-7 I213A WITH DEVD-CHO INHIBITOR BOUND TO ACTIVE SITE
101, d3deiA_, 0.9601, 0.48, 0.991, 231, 231, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
102, p4qulA_, 0.9597, 0.30, 0.991, 230, 230, CASPASE-3 F55W
103, d1kmcB_, 0.9597, 0.83, 0.567, 234, 233, CRYSTAL STRUCTURE OF THE CASPASE-7 / XIAP-BIR2 COMPLEX
104, d1rhq.2, 0.9595, 0.49, 0.996, 231, 231, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A BROMOMETHOXYPHENYL INHIBITOR
105, d1rhq.1, 0.9595, 0.49, 0.996, 231, 231, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A BROMOMETHOXYPHENYL INHIBITOR
106, p4fdlA_, 0.9594, 0.63, 0.573, 232, 232, CRYSTAL STRUCTURE OF CASPASE-7
107, p5ibrA_, 0.9590, 0.46, 0.991, 230, 230, CASPASE 3 V266K
108, d1i4oB_, 0.9588, 0.76, 0.573, 232, 232, CRYSTAL STRUCTURE OF THE XIAP/CASPASE-7 COMPLEX
109, d1rhr.1, 0.9585, 0.52, 0.996, 231, 231, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-3 WITH A CINNAMIC ACID METHYL ESTER INHIBITOR
110, p4qudB_, 0.9571, 0.51, 0.991, 230, 230, CASPASE-3 T140F
111, d1f1jB_, 0.9570, 0.58, 0.571, 231, 231, CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ACETYL-ASP-GLU-VAL-ASP- CHO
112, d1m72B_, 0.9564, 1.22, 0.404, 248, 235, CRYSTAL STRUCTURE OF CASPASE-1 FROM SPODOPTERA FRUGIPERDA
113, d1i51.2, 0.9564, 0.60, 0.571, 231, 231, CRYSTAL STRUCTURE OF CASPASE-7 COMPLEXED WITH XIAP
114, d4jj8A_, 0.9563, 0.60, 0.576, 231, 231, CASPASE-3 SPECIFIC UNNATURAL AMINO ACID PEPTIDES
115, d1m72A_, 0.9563, 1.20, 0.404, 247, 235, CRYSTAL STRUCTURE OF CASPASE-1 FROM SPODOPTERA FRUGIPERDA
116, d1m72C1, 0.9562, 1.22, 0.404, 251, 235, CRYSTAL STRUCTURE OF CASPASE-1 FROM SPODOPTERA FRUGIPERDA
117, d4jj8B_, 0.9561, 1.22, 0.404, 251, 235, CASPASE-3 SPECIFIC UNNATURAL AMINO ACID PEPTIDES
118, d4hvaB_, 0.9553, 0.61, 0.576, 231, 231, MECHANISTIC AND STRUCTURAL UNDERSTANDING OF UNCOMPETITIVE INHIBITORS OF CASPASE-6
119, d1i51.1, 0.9549, 1.47, 0.435, 241, 237, CRYSTAL STRUCTURE OF CASPASE-7 COMPLEXED WITH XIAP
120, p5ibrC_, 0.9546, 0.65, 0.571, 231, 231, CASPASE 3 V266K
121, d4hvaA_, 0.9541, 0.50, 0.991, 229, 229, MECHANISTIC AND STRUCTURAL UNDERSTANDING OF UNCOMPETITIVE INHIBITORS OF CASPASE-6
122, p3s70C_, 0.9535, 1.54, 0.435, 238, 237, CRYSTAL STRUCTURE OF ACTIVE CASPASE-6 BOUND WITH AC-VEID-CHO SOLVED BY AS-SAD
123, d3od5A_, 0.9534, 1.56, 0.435, 239, 237, CRYSTAL STRUCTURE OF ACTIVE CASPASE-6 BOUND WITH AC-VEID-CHO
124, p3s70A_, 0.9530, 1.56, 0.435, 240, 237, CRYSTAL STRUCTURE OF ACTIVE CASPASE-6 BOUND WITH AC-VEID-CHO SOLVED BY AS-SAD
125, d3od5B_, 0.9528, 1.57, 0.435, 241, 237, CRYSTAL STRUCTURE OF ACTIVE CASPASE-6 BOUND WITH AC-VEID-CHO
126, d1f1jA_, 0.9528, 1.57, 0.435, 240, 237, CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ACETYL-ASP-GLU-VAL-ASP- CHO
127, d3dehD_, 0.9479, 0.58, 0.574, 230, 230, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
128, d3dejD_, 0.9472, 0.46, 0.991, 228, 228, CRYSTAL STRUCTURES OF CASPASE-3 WITH BOUND ISOQUINOLINE-13 4-TRIONE DERIVATIVE INHIBITORS
129, d4hqrB_, 0.9465, 0.49, 0.991, 228, 228, CRYSTAL STRUCTURE OF MUTANT FORM OF CASPASE-7
130, d1pyo.2, 0.9351, 0.95, 0.570, 230, 230, CRYSTAL STRUCTURE OF HUMAN CASPASE-2 IN COMPLEX WITH ACETYL-LEU-ASP- GLU-SER-ASP-CHO
131, d4jr0A1, 0.9320, 1.57, 0.306, 260, 235, HUMAN PROCASPASE-3 BOUND TO AC-DEVD-CMK
132, d1pyo.1, 0.9320, 1.57, 0.306, 260, 235, CRYSTAL STRUCTURE OF HUMAN CASPASE-2 IN COMPLEX WITH ACETYL-LEU-ASP- GLU-SER-ASP-CHO
133, d1k86A_, 0.9287, 0.69, 1.000, 225, 225, CRYSTAL STRUCTURE OF CASPASE-7
134, d4jr0B1, 0.9279, 1.58, 0.312, 257, 234, HUMAN PROCASPASE-3 BOUND TO AC-DEVD-CMK
135, d4jr2A1, 0.9236, 1.32, 0.565, 232, 230, HUMAN PROCASPASE-7/CASPASE-7 HETERODIMER BOUND TO AC-DEVD-CMK
136, d4ps1A_, 0.9200, 0.67, 1.000, 224, 224, CASPASE-8 SPECIFIC UNNATURAL AMINO ACID PEPTIDES
137, d4jr1B1, 0.9200, 0.59, 0.574, 223, 223, HUMAN PROCASPASE-7 BOUND TO AC-DEVD-CMK
138, d1f9e.2, 0.9198, 1.20, 0.399, 238, 228, CASPASE-8 SPECIFICITY PROBED AT SUBSITE S4: CRYSTAL STRUCTURE OF THE CASPASE-8-Z-DEVD-CHO
139, d4jj7A_, 0.9195, 1.14, 0.573, 227, 225, CASPASE-3 SPECIFIC UNNATURAL AMINO ACID-BASED PEPTIDES
140, d1f9e.5, 0.9194, 1.32, 0.397, 242, 229, CASPASE-8 SPECIFICITY PROBED AT SUBSITE S4: CRYSTAL STRUCTURE OF THE CASPASE-8-Z-DEVD-CHO
141, d1f9e.3, 0.9193, 1.24, 0.390, 241, 228, CASPASE-8 SPECIFICITY PROBED AT SUBSITE S4: CRYSTAL STRUCTURE OF THE CASPASE-8-Z-DEVD-CHO
142, d2funB_, 0.9191, 1.33, 0.397, 242, 229, ALTERNATIVE P35-CASPASE-8 COMPLEX
143, d4ps1B_, 0.9189, 1.33, 0.397, 242, 229, CASPASE-8 SPECIFIC UNNATURAL AMINO ACID PEPTIDES
144, d1i4eB_, 0.9189, 1.31, 0.397, 243, 229, CRYSTAL STRUCTURE OF THE CASPASE-8/P35 COMPLEX
145, d1f9e.6, 0.9188, 1.23, 0.399, 238, 228, CASPASE-8 SPECIFICITY PROBED AT SUBSITE S4: CRYSTAL STRUCTURE OF THE CASPASE-8-Z-DEVD-CHO
146, d1f9e.1, 0.9188, 1.31, 0.397, 243, 229, CASPASE-8 SPECIFICITY PROBED AT SUBSITE S4: CRYSTAL STRUCTURE OF THE CASPASE-8-Z-DEVD-CHO
147, p4m9rA_, 0.9185, 1.31, 0.397, 243, 229, CRYSTAL STRUCTURE OF CED-3
148, d1f9e.4, 0.9185, 1.34, 0.397, 242, 229, CASPASE-8 SPECIFICITY PROBED AT SUBSITE S4: CRYSTAL STRUCTURE OF THE CASPASE-8-Z-DEVD-CHO
149, d4przA_, 0.9184, 1.34, 0.397, 242, 229, CASPASE-8 SPECIFIC UNNATURAL AMINO ACID PEPTIDES
150, d4ps1C_, 0.9182, 1.36, 0.371, 256, 229, CASPASE-8 SPECIFIC UNNATURAL AMINO ACID PEPTIDES
151, d1qtn.1, 0.9179, 1.36, 0.371, 256, 229, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TETRAPEPTIDE INHIBITOR ACE-IETD-ALDEHYDE
152, d1qdu.6, 0.9177, 1.34, 0.397, 242, 229, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TRIPEPTIDE KETONE INHIBITOR ZEVD-DCBMK
153, d1qdu.4, 0.9177, 1.26, 0.390, 240, 228, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TRIPEPTIDE KETONE INHIBITOR ZEVD-DCBMK
154, d1qdu.2, 0.9175, 1.27, 0.390, 237, 228, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TRIPEPTIDE KETONE INHIBITOR ZEVD-DCBMK
155, d2funD_, 0.9173, 1.26, 0.390, 242, 228, ALTERNATIVE P35-CASPASE-8 COMPLEX
156, d1qdu.5, 0.9160, 1.25, 0.399, 241, 228, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TRIPEPTIDE KETONE INHIBITOR ZEVD-DCBMK
157, d1qdu.3, 0.9157, 1.25, 0.399, 241, 228, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TRIPEPTIDE KETONE INHIBITOR ZEVD-DCBMK
158, d4ps1D_, 0.9155, 1.25, 0.399, 241, 228, CASPASE-8 SPECIFIC UNNATURAL AMINO ACID PEPTIDES
159, d1qdu.1, 0.9147, 1.22, 0.399, 241, 228, CRYSTAL STRUCTURE OF THE COMPLEX OF CASPASE-8 WITH THE TRIPEPTIDE KETONE INHIBITOR ZEVD-DCBMK
160, p3v3kC_, 0.9122, 1.30, 0.399, 241, 228, HUMAN CASPASE 9 IN COMPLEX WITH BACTERIAL EFFECTOR PROTEIN
161, p3v3kG_, 0.9120, 1.31, 0.399, 241, 228, HUMAN CASPASE 9 IN COMPLEX WITH BACTERIAL EFFECTOR PROTEIN
162, p3v3kK_, 0.9113, 1.20, 0.392, 236, 227, HUMAN CASPASE 9 IN COMPLEX WITH BACTERIAL EFFECTOR PROTEIN
163, p3v3kE_, 0.9106, 1.33, 0.399, 241, 228, HUMAN CASPASE 9 IN COMPLEX WITH BACTERIAL EFFECTOR PROTEIN
164, p3v3kO_, 0.9102, 1.26, 0.385, 237, 226, HUMAN CASPASE 9 IN COMPLEX WITH BACTERIAL EFFECTOR PROTEIN
165, p3v3kA_, 0.9093, 1.27, 0.385, 235, 226, HUMAN CASPASE 9 IN COMPLEX WITH BACTERIAL EFFECTOR PROTEIN
166, p3v3kM_, 0.9089, 1.27, 0.385, 237, 226, HUMAN CASPASE 9 IN COMPLEX WITH BACTERIAL EFFECTOR PROTEIN
167, d1k86B_, 0.9051, 1.47, 0.383, 243, 227, CRYSTAL STRUCTURE OF CASPASE-7
168, d1jxqC1, 0.8989, 1.31, 0.385, 237, 226, STRUCTURE OF CLEAVED CARD DOMAIN DELETED CASPASE-9
169, d1jxqA1, 0.8987, 1.29, 0.385, 245, 226, STRUCTURE OF CLEAVED CARD DOMAIN DELETED CASPASE-9
170, d4n5dA_, 0.8933, 1.29, 0.385, 245, 226, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6: CPD1
171, p3v3kI_, 0.8923, 1.51, 0.383, 245, 227, HUMAN CASPASE 9 IN COMPLEX WITH BACTERIAL EFFECTOR PROTEIN
172, d4n7mA_, 0.8906, 1.79, 0.566, 232, 226, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6
173, d4nblA_, 0.8905, 1.65, 0.387, 241, 225, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6
174, d4nbkA_, 0.8903, 1.66, 0.387, 241, 225, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6
175, d4n7jA_, 0.8896, 2.09, 0.432, 257, 229, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6
176, d4nbnA_, 0.8894, 1.21, 0.389, 232, 221, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6
177, d4n6gA_, 0.8893, 2.13, 0.432, 256, 229, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6
178, d4n5dB_, 0.8850, 2.15, 0.432, 258, 229, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6: CPD1
179, d4n7jB_, 0.8847, 2.15, 0.432, 258, 229, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6
180, d4n7mB_, 0.8846, 2.16, 0.432, 256, 229, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6
181, d4n6gB_, 0.8845, 2.15, 0.432, 256, 229, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6
182, d4nblB_, 0.8842, 2.16, 0.432, 257, 229, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6
183, d4nbnB_, 0.8838, 2.18, 0.432, 257, 229, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6
184, d4nbkB_, 0.8837, 2.06, 0.438, 243, 226, TAILORING SMALL MOLECULES FOR AN ALLOSTERIC SITE ON PROCASPASE-6
185, d4hqrA_, 0.8822, 2.06, 0.438, 243, 226, CRYSTAL STRUCTURE OF MUTANT FORM OF CASPASE-7
186, p4ejfC_, 0.8809, 2.06, 0.438, 243, 226, ALLOSTERIC PEPTIDES THAT BIND TO A CASPASE ZYMOGEN AND MEDIATE CASPASE TETRAMERIZATION
187, p4ejfB_, 0.8802, 2.19, 0.432, 243, 227, ALLOSTERIC PEPTIDES THAT BIND TO A CASPASE ZYMOGEN AND MEDIATE CASPASE TETRAMERIZATION
188, p4ejfD_, 0.8799, 2.24, 0.432, 242, 227, ALLOSTERIC PEPTIDES THAT BIND TO A CASPASE ZYMOGEN AND MEDIATE CASPASE TETRAMERIZATION
189, d3v6lB_, 0.8796, 2.24, 0.432, 242, 227, CRYSTAL STRUCTURE OF CASPASE-6 INACTIVATION MUTATION
190, p4ejfA_, 0.8785, 2.25, 0.432, 243, 227, ALLOSTERIC PEPTIDES THAT BIND TO A CASPASE ZYMOGEN AND MEDIATE CASPASE TETRAMERIZATION
191, p4iyrA_, 0.8776, 1.24, 0.560, 217, 216, CRYSTAL STRUCTURE OF FULL-LENGTH CASPASE-6 ZYMOGEN
192, d1k88A_, 0.8754, 2.23, 0.436, 243, 227, CRYSTAL STRUCTURE OF PROCASPASE-7
193, d3v6lA_, 0.8751, 2.16, 0.434, 243, 226, CRYSTAL STRUCTURE OF CASPASE-6 INACTIVATION MUTATION
194, d4jr1A1, 0.8720, 2.31, 0.432, 243, 227, HUMAN PROCASPASE-7 BOUND TO AC-DEVD-CMK
195, d1rwk.1, 0.8651, 2.26, 0.438, 241, 226, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 3-(2-MERCAPTO- ACETYLAMINO)-4-OXO-PENTANOIC ACID
196, d1ibc.1, 0.8648, 2.33, 0.436, 243, 227, CRYSTAL STRUCTURE OF INHIBITED INTERLEUKIN-1BETA CONVERTING ENZYME
197, d1rwm.1, 0.8644, 2.34, 0.436, 248, 227, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 4-OXO-3-[2-(5- {[4-(QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-METHYL}-THIOPHEN-2-YL)- ACETYLAMINO]-PENTANOIC ACID
198, d1rwn.1, 0.8636, 1.90, 0.547, 227, 223, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 3-{2-ETHYL-6-[4- (QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-HEXANOYLAMINO}-4-OXO-BUTYRIC ACID
199, d1rwv.1, 0.8635, 2.29, 0.444, 239, 225, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 5-[5-(1- CARBOXYMETHYL-2-OXO-PROPYLCARBAMOYL)-5-PHENYL-PENTYLSULFAMOYL]-2- HYDROXY-BENZOIC ACID
200, d1ice.1, 0.8634, 0.91, 0.568, 222, 213, STRUCTURE AND MECHANISM OF INTERLEUKIN-1BETA CONVERTING ENZYME
201, d1rwx.1, 0.8633, 2.06, 0.290, 261, 224, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 4-OXO-3-{6-[4- (QUINOXALIN-2-YLOXY)-BENZOYLAMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}- BUTYRIC ACID
202, d1sc3.1, 0.8631, 2.24, 0.289, 255, 225, CRYSTAL STRUCTURE OF THE HUMAN CASPASE-1 C285A MUTANT IN COMPLEX WITH MALONATE
203, d1rwp.1, 0.8631, 2.06, 0.290, 261, 224, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 3-{6-[(8-HYDROXY- QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO- BUTYRIC ACID
204, d1rwo.1, 0.8631, 2.08, 0.290, 261, 224, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 4-OXO-3-{6-[4- (QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}- PENTANOIC ACID
205, d1bmq.1, 0.8628, 2.10, 0.290, 261, 224, CRYSTAL STRUCTURE OF THE COMPLEX OF INTERLEUKIN-1BETA CONVERTING ENZYME (ICE) WITH A PEPTIDE BASED INHIBITOR (3S )-N-METHANESULFONYL-3-({1-[N-(2-NAPHTOYL)-L-VALYL]-L- PROLYL }AMINO)-4-OXOBUTANAMIDE
206, d1rww.1, 0.8622, 2.21, 0.289, 255, 225, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH 4-OXO-3-[(6-{[4- (QUINOXALIN-2-YLAMINO)-BENZOYLAMINO]-METHYL}-PYRIDINE-3-CARBONYL)- AMINO]-BUTYRIC ACID
207, d3nr2A_, 0.8602, 2.09, 0.290, 266, 224, CRYSTAL STRUCTURE OF CASPASE-6 ZYMOGEN
208, d3h11B_, 0.8596, 2.09, 0.286, 261, 224, ZYMOGEN CASPASE-8:C-FLIPL PROTEASE DOMAIN COMPLEX
209, p5v6uB_, 0.8582, 2.11, 0.290, 261, 224, CRYSTAL STRUCTURE OF HUMAN CASPASE-7 SOAKED WITH ALLOSTERIC INHIBITOR 2-[(2-ACETYLPHENYL)SULFANYL]BENZOIC ACID
210, d1gqfA1, 0.8580, 2.11, 0.290, 261, 224, CRYSTAL STRUCTURE OF HUMAN PROCASPASE-7
211, d1gqfB1, 0.8549, 2.23, 0.289, 255, 225, CRYSTAL STRUCTURE OF HUMAN PROCASPASE-7
212, d3nr2B_, 0.8537, 2.10, 0.290, 263, 224, CRYSTAL STRUCTURE OF CASPASE-6 ZYMOGEN
213, d2ar9A_, 0.8505, 1.98, 0.454, 233, 218, CRYSTAL STRUCTURE OF A DIMERIC CASPASE-9
214, d1k88B_, 0.8498, 1.40, 0.402, 229, 214, CRYSTAL STRUCTURE OF PROCASPASE-7
215, d4hq0B_, 0.8495, 1.03, 0.555, 213, 209, CRYSTAL STRUCTURE OF MUTANT FORM OF CASPASE-7
216, d4hq0A_, 0.8493, 2.35, 0.525, 257, 221, CRYSTAL STRUCTURE OF MUTANT FORM OF CASPASE-7
217, p5v6zB_, 0.8462, 2.35, 0.525, 257, 221, CRYSTAL STRUCTURE OF HUMAN CASPASE-7 SOAKED WITH ALLOSTERIC INHIBITOR 2-{[2-(4-CHLOROPHENYL)-2-OXOETHYL]SULFANYL}BENZOIC ACID
218, p5v6uA_, 0.8458, 2.43, 0.520, 256, 221, CRYSTAL STRUCTURE OF HUMAN CASPASE-7 SOAKED WITH ALLOSTERIC INHIBITOR 2-[(2-ACETYLPHENYL)SULFANYL]BENZOIC ACID
219, d2ar9C_, 0.8448, 2.11, 0.452, 230, 217, CRYSTAL STRUCTURE OF A DIMERIC CASPASE-9
220, d1sc1.1, 0.8340, 1.73, 0.407, 230, 214, CRYSTAL STRUCTURE OF AN ACTIVE-SITE LIGAND-FREE FORM OF THE HUMAN CASPASE-1 C285A MUTANT
221, p2nn3D_, 0.8330, 2.16, 0.542, 234, 216, STRUCTURE OF PRO-SF-CASPASE-1
222, d1jxqB1, 0.8318, 1.32, 0.555, 217, 209, STRUCTURE OF CLEAVED CARD DOMAIN DELETED CASPASE-9
223, d1jxqD1, 0.8316, 1.42, 0.562, 210, 210, STRUCTURE OF CLEAVED CARD DOMAIN DELETED CASPASE-9
224, p2nn3C_, 0.8307, 0.96, 0.549, 210, 206, STRUCTURE OF PRO-SF-CASPASE-1
225, p5v6zA_, 0.8298, 0.70, 0.561, 205, 205, CRYSTAL STRUCTURE OF HUMAN CASPASE-7 SOAKED WITH ALLOSTERIC INHIBITOR 2-{[2-(4-CHLOROPHENYL)-2-OXOETHYL]SULFANYL}BENZOIC ACID
226, d3s8eD_, 0.8261, 1.82, 0.407, 230, 214, PHOSPHORYLATION REGULATES ASSEMBLY OF THE CASPASE-6 SUBSTRATE-BINDING GROOVE
227, d1sc4.1, 0.8247, 2.31, 0.271, 255, 221, CRYSTAL STRUCTURE OF THE HUMAN CASPASE-1 C285A MUTANT AFTER REMOVAL OF MALONATE
228, d3s8eC_, 0.8243, 2.45, 0.390, 249, 218, PHOSPHORYLATION REGULATES ASSEMBLY OF THE CASPASE-6 SUBSTRATE-BINDING GROOVE
229, d3s8eF_, 0.8230, 1.87, 0.373, 225, 212, PHOSPHORYLATION REGULATES ASSEMBLY OF THE CASPASE-6 SUBSTRATE-BINDING GROOVE
230, d3s8eG_, 0.8225, 1.87, 0.373, 225, 212, PHOSPHORYLATION REGULATES ASSEMBLY OF THE CASPASE-6 SUBSTRATE-BINDING GROOVE
231, d3s8eA_, 0.8223, 2.62, 0.374, 235, 219, PHOSPHORYLATION REGULATES ASSEMBLY OF THE CASPASE-6 SUBSTRATE-BINDING GROOVE
232, d2ar9B_, 0.8207, 0.69, 0.552, 201, 201, CRYSTAL STRUCTURE OF A DIMERIC CASPASE-9
233, d3s8eE_, 0.8205, 2.12, 0.438, 221, 210, PHOSPHORYLATION REGULATES ASSEMBLY OF THE CASPASE-6 SUBSTRATE-BINDING GROOVE
234, d1shjB_, 0.8203, 2.20, 0.273, 246, 216, CASPASE-7 IN COMPLEX WITH DICA ALLOSTERIC INHIBITOR
235, d3s8eH_, 0.8193, 2.12, 0.445, 219, 209, PHOSPHORYLATION REGULATES ASSEMBLY OF THE CASPASE-6 SUBSTRATE-BINDING GROOVE
236, d3s8eB_, 0.8181, 2.19, 0.443, 222, 210, PHOSPHORYLATION REGULATES ASSEMBLY OF THE CASPASE-6 SUBSTRATE-BINDING GROOVE
237, d2ar9D_, 0.8174, 2.24, 0.440, 216, 209, CRYSTAL STRUCTURE OF A DIMERIC CASPASE-9
238, p3e4cA_, 0.8149, 2.03, 0.442, 219, 208, PROCASPASE-1 ZYMOGEN DOMAIN CRYSTAL STRUCUTRE
239, d1shjA_, 0.8148, 2.03, 0.393, 232, 211, CASPASE-7 IN COMPLEX WITH DICA ALLOSTERIC INHIBITOR
240, d1nw9B_, 0.8147, 2.04, 0.442, 219, 208, STRUCTURE OF CASPASE-9 IN AN INHIBITORY COMPLEX WITH XIAP- BIR3
241, d1shlB_, 0.8099, 1.77, 0.546, 209, 205, CASPASE-7 IN COMPLEX WITH FICA ALLOSTERIC INHIBITOR
242, d3v6mA_, 0.8089, 2.13, 0.447, 217, 208, INHIBITION OF CASPASE-6 ACTIVITY BY SINGLE MUTATION OUTSIDE THE ACTIVE SITE
243, d3v6mJ_, 0.8079, 1.95, 0.447, 214, 206, INHIBITION OF CASPASE-6 ACTIVITY BY SINGLE MUTATION OUTSIDE THE ACTIVE SITE
244, p3e4cB_, 0.8063, 2.03, 0.390, 231, 210, PROCASPASE-1 ZYMOGEN DOMAIN CRYSTAL STRUCUTRE
245, d3v6mC_, 0.8054, 2.37, 0.274, 271, 215, INHIBITION OF CASPASE-6 ACTIVITY BY SINGLE MUTATION OUTSIDE THE ACTIVE SITE
246, p4feaB_, 0.8053, 2.37, 0.274, 271, 215, CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ALLOSTERIC INHIBITOR
247, d1shlA_, 0.8051, 1.63, 0.550, 208, 202, CASPASE-7 IN COMPLEX WITH FICA ALLOSTERIC INHIBITOR
248, d3v6mG_, 0.8028, 2.07, 0.362, 238, 210, INHIBITION OF CASPASE-6 ACTIVITY BY SINGLE MUTATION OUTSIDE THE ACTIVE SITE
249, d3v6mI_, 0.8025, 1.31, 0.553, 200, 199, INHIBITION OF CASPASE-6 ACTIVITY BY SINGLE MUTATION OUTSIDE THE ACTIVE SITE
250, d3v6mD_, 0.8025, 1.85, 0.446, 205, 202, INHIBITION OF CASPASE-6 ACTIVITY BY SINGLE MUTATION OUTSIDE THE ACTIVE SITE
251, d3v6mB_, 0.8020, 1.81, 0.441, 206, 202, INHIBITION OF CASPASE-6 ACTIVITY BY SINGLE MUTATION OUTSIDE THE ACTIVE SITE
252, d3v6mF_, 0.8017, 2.22, 0.280, 257, 211, INHIBITION OF CASPASE-6 ACTIVITY BY SINGLE MUTATION OUTSIDE THE ACTIVE SITE
253, p2fp3A_, 0.7921, 1.79, 0.443, 205, 201, CRYSTAL STRUCTURE OF THE DROSOPHILA INITIATOR CASPASE DRONC
254, p2wdpA_, 0.7841, 0.81, 0.541, 196, 196, CRYSTAL STRUCTURE OF LIGAND FREE HUMAN CASPASE-6
255, p2wdpB_, 0.7815, 0.89, 0.541, 198, 196, CRYSTAL STRUCTURE OF LIGAND FREE HUMAN CASPASE-6
256, p2wdpD_, 0.7805, 1.76, 0.445, 204, 200, CRYSTAL STRUCTURE OF LIGAND FREE HUMAN CASPASE-6
257, p4m9rB_, 0.7804, 1.77, 0.445, 204, 200, CRYSTAL STRUCTURE OF CED-3
258, p4fxoB_, 0.7794, 1.78, 0.445, 204, 200, ZINC-MEDIATED ALLOSTERIC INHIBITON OF CASPASE-6
259, p2wdpC_, 0.7730, 1.78, 0.445, 204, 200, CRYSTAL STRUCTURE OF LIGAND FREE HUMAN CASPASE-6
260, p3nkfD_, 0.7707, 1.60, 0.447, 203, 199, CRYSTAL STRUCTURE OF HUMAN LIGAND-FREE MATURE CASPASE-6 WITH INTERSUBUNIT LINKER ATTACHED
261, d4jqyB1, 0.7668, 2.56, 0.227, 254, 211, HUMAN PROCASPASE-3 CRYSTAL FORM 1
262, d4jqzA1, 0.7647, 2.56, 0.227, 254, 211, HUMAN PROCASPASE-3 CRYSTAL FORM 2
263, p3nkfC_, 0.7646, 2.84, 0.458, 224, 212, CRYSTAL STRUCTURE OF HUMAN LIGAND-FREE MATURE CASPASE-6 WITH INTERSUBUNIT LINKER ATTACHED
264, d3h13A_, 0.7639, 2.90, 0.446, 227, 213, C-FLIPL PROTEASE-LIKE DOMAIN
265, p4fxoC_, 0.7602, 3.15, 0.445, 230, 218, ZINC-MEDIATED ALLOSTERIC INHIBITON OF CASPASE-6
266, d3h11A_, 0.7601, 1.51, 0.367, 223, 196, ZYMOGEN CASPASE-8:C-FLIPL PROTEASE DOMAIN COMPLEX
267, p3nkfA_, 0.7590, 3.01, 0.434, 227, 212, CRYSTAL STRUCTURE OF HUMAN LIGAND-FREE MATURE CASPASE-6 WITH INTERSUBUNIT LINKER ATTACHED
268, p4fxoD_, 0.7574, 3.15, 0.442, 227, 215, ZINC-MEDIATED ALLOSTERIC INHIBITON OF CASPASE-6
269, p3v4lA1, 0.7565, 3.02, 0.462, 220, 210, MOUSE MALT1(CASPASE-IG3 DOMAINS) IN COMPLEX WITH A IRREVERSIBLE PEPTIDIC INHIBITOR
270, d3k7eA_, 0.7551, 1.95, 0.944, 203, 196, CRYSTAL STRUCTURE OF HUMAN LIGAND-FREE MATURE CASPASE-6
271, p3v4oA_, 0.7547, 1.74, 0.979, 196, 193, HUMAN MALT1 (CASPASE DOMAIN) IN COMPLEX WITH AN IRREVERSIBLE PEPTIDIC INHIBITOR
272, p3nkfB_, 0.7533, 2.80, 0.449, 222, 207, CRYSTAL STRUCTURE OF HUMAN LIGAND-FREE MATURE CASPASE-6 WITH INTERSUBUNIT LINKER ATTACHED
273, d4jqyA1, 0.7529, 2.14, 0.290, 208, 200, HUMAN PROCASPASE-3 CRYSTAL FORM 1
274, d3k7eC_, 0.7528, 2.97, 0.447, 220, 206, CRYSTAL STRUCTURE OF HUMAN LIGAND-FREE MATURE CASPASE-6
275, p3uoaB1, 0.7519, 2.36, 0.289, 212, 201, CRYSTAL STRUCTURE OF THE MALT1 PARACASPASE (P21 FORM)
276, p3uo8C1, 0.7518, 2.36, 0.289, 212, 201, CRYSTAL STRUCTURE OF THE MALT1 PARACASPASE (P1 FORM)
277, p4i1pC1, 0.7515, 3.12, 0.459, 219, 209, HUMAN MALT1 (CASPASE-IG3) IN COMPLEX WITH ACTIVITY BASED-PROBE
278, p3uoaC1, 0.7513, 2.88, 0.446, 220, 204, CRYSTAL STRUCTURE OF THE MALT1 PARACASPASE (P21 FORM)
279, p4iyrB_, 0.7510, 2.19, 0.170, 245, 200, CRYSTAL STRUCTURE OF FULL-LENGTH CASPASE-6 ZYMOGEN
280, p3uo8B1, 0.7510, 2.19, 0.170, 245, 200, CRYSTAL STRUCTURE OF THE MALT1 PARACASPASE (P1 FORM)
281, p4i1pA1, 0.7493, 2.89, 0.463, 214, 205, HUMAN MALT1 (CASPASE-IG3) IN COMPLEX WITH ACTIVITY BASED-PROBE
282, p4fxoA_, 0.7479, 2.23, 0.185, 234, 200, ZINC-MEDIATED ALLOSTERIC INHIBITON OF CASPASE-6
283, d3k7eD_, 0.7473, 2.96, 0.456, 213, 206, CRYSTAL STRUCTURE OF HUMAN LIGAND-FREE MATURE CASPASE-6
284, d4jqzB1, 0.7246, 1.69, 0.979, 192, 189, HUMAN PROCASPASE-3 CRYSTAL FORM 2
285, p3k7eB_, 0.7193, 2.90, 0.456, 212, 204, CRYSTAL STRUCTURE OF HUMAN LIGAND-FREE MATURE CASPASE-6
286, p3bijA_, 0.7172, 2.14, 0.182, 230, 198, CRYSTAL STRUCTURE OF PROTEIN GSU0716 FROM GEOBACTER SULFURREDUCENS. NORTHEAST STRUCTURAL GENOMICS TARGET GSR13
287, d3sirA_, 0.7160, 2.14, 0.182, 233, 198, CRYSTAL STRUCTURE OF DRICE
288, p3bijB_, 0.7136, 2.15, 0.187, 231, 198, CRYSTAL STRUCTURE OF PROTEIN GSU0716 FROM GEOBACTER SULFURREDUCENS. NORTHEAST STRUCTURAL GENOMICS TARGET GSR13
289, p3bijC_, 0.7131, 2.15, 0.182, 233, 198, CRYSTAL STRUCTURE OF PROTEIN GSU0716 FROM GEOBACTER SULFURREDUCENS. NORTHEAST STRUCTURAL GENOMICS TARGET GSR13
290, p3v55A1, 0.7120, 1.81, 0.463, 191, 188, HUMAN MALT1 (334-719) IN ITS LIGAND FREE FORM
291, p4i1rA1, 0.7037, 2.16, 0.182, 230, 198, HUMAN MALT1 (CASPASE-IG3) IN COMPLEX WITH THIORIDAZINE
292, p5nijB1, 0.6977, 2.18, 0.182, 244, 198, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA LEGUMAIN ISOFORM GAMMA IN TWO-CHAIN ACTIVATION STATE
293, p5nijA1, 0.6931, 2.89, 0.448, 219, 201, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA LEGUMAIN ISOFORM GAMMA IN TWO-CHAIN ACTIVATION STATE
294, p4nomA1, 0.6930, 2.98, 0.463, 213, 203, CRYSTAL STRUCTURE OF ASPARAGINYL ENDOPEPTIDASE (AEP)/LEGUMAIN ACTIVATED AT PH 4.5
295, p5nijC1, 0.6927, 1.15, 0.989, 181, 177, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA LEGUMAIN ISOFORM GAMMA IN TWO-CHAIN ACTIVATION STATE
296, p5nijD1, 0.6914, 2.86, 0.448, 200, 194, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA LEGUMAIN ISOFORM GAMMA IN TWO-CHAIN ACTIVATION STATE
297, p4feaA_, 0.6906, 2.69, 0.137, 258, 197, CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ALLOSTERIC INHIBITOR
298, p5h0iB1, 0.6898, 2.69, 0.137, 258, 197, NAME TO BE RELEASED WHEN PUBLISHED
299, p5zbiB1, 0.6885, 3.00, 0.399, 214, 193, CRYSTAL STRUCTURE OF ASPARAGINYL ENDOPEPTIDASES FROM VIOLA CANADENSIS 
300, p4f6oA_, 0.6879, 2.65, 0.133, 255, 196, CRYSTAL STRUCTURE OF THE YEAST METACASPASE YCA1
301, p5zbiA1, 0.6875, 2.63, 0.133, 257, 196, CRYSTAL STRUCTURE OF ASPARAGINYL ENDOPEPTIDASES FROM VIOLA CANADENSIS 
302, p6aztA_, 0.6871, 2.48, 0.181, 230, 193, ASPARAGINYL ENDOPEPTIDASE 1 BOUND TO AAN PEPTIDE A TETRAHEDRAL INTERMEDIATE
303, p5h0iA1, 0.6861, 2.40, 0.180, 214, 189, NAME TO BE RELEASED WHEN PUBLISHED
304, p4f6pA_, 0.6853, 3.08, 0.091, 293, 198, CRYSTAL STRUCTURE OF THE YEAST METACASPASE YCA1 C276A MUTANT
305, p4aw9A_, 0.6848, 3.07, 0.092, 294, 196, CRYSTAL STRUCTURE OF ACTIVE LEGUMAIN IN COMPLEX WITH YVAD-CMK
306, p4awaA_, 0.6847, 3.07, 0.092, 294, 196, CRYSTAL STRUCTURE OF ACTIVE LEGUMAIN IN COMPLEX WITH YVAD-CMK AT PH 5.0
307, p4awbA_, 0.6842, 2.78, 0.124, 291, 193, CRYSTAL STRUCTURE OF ACTIVE LEGUMAIN IN COMPLEX WITH AAN-CMK
308, p4awbB_, 0.6841, 3.06, 0.092, 294, 196, CRYSTAL STRUCTURE OF ACTIVE LEGUMAIN IN COMPLEX WITH AAN-CMK
309, p4n6oA_, 0.6830, 3.08, 0.092, 293, 196, CRYSTAL STRUCTURE OF REDUCED LEGUMAIN IN COMPLEX WITH CYSTATIN E/M
310, p4d3zA1, 0.6814, 1.05, 0.535, 170, 170, THE STRUCTURE OF INACTIVE PROLEGUMAIN FROM CHINESE HAMSTER TRIGONAL SPACE GROUP.
311, p5luaB_, 0.6810, 2.76, 0.109, 282, 192, CRYSTAL STRUCTURE OF HUMAN LEGUMAIN (AEP) IN COMPLEX WITH COMPOUND 11B
312, p4nokA1, 0.6809, 2.77, 0.099, 297, 192, CRYSTAL STRUCTURE OF PROENZYME ASPARAGINYL ENDOPEPTIDASE (AEP) /LEGUMAIN AT PH 7.5
313, p5lubB_, 0.6808, 2.81, 0.156, 268, 192, CRYSTAL STRUCTURE OF HUMAN LEGUMAIN (AEP) IN COMPLEX WITH COMPOUND 11
314, p4nolB1, 0.6808, 2.81, 0.156, 268, 192, CRYSTAL STRUCTURE OF PROENZYME ASPARAGINYL ENDOPEPTIDASE (AEP) /LEGUMAIN MUTANT D233A AT PH 7.5
315, p4nojA_, 0.6806, 2.77, 0.099, 299, 192, CRYSTAL STRUCTURE OF THE MATURE FORM OF ASPARAGINYL ENDOPEPTIDASE (AEP)/LEGUMAIN ACTIVATED AT PH 3.5
316, p5lubA_, 0.6805, 2.70, 0.084, 273, 190, CRYSTAL STRUCTURE OF HUMAN LEGUMAIN (AEP) IN COMPLEX WITH COMPOUND 11
317, p4nolA1, 0.6805, 2.76, 0.110, 282, 191, CRYSTAL STRUCTURE OF PROENZYME ASPARAGINYL ENDOPEPTIDASE (AEP) /LEGUMAIN MUTANT D233A AT PH 7.5
318, p4n6nA_, 0.6803, 2.70, 0.141, 261, 191, CRYSTAL STRUCTURE OF OXIDIZED LEGUMAIN IN COMPLEX WITH CYSTATIN E/M
319, p5luaA_, 0.6802, 2.82, 0.126, 263, 191, CRYSTAL STRUCTURE OF HUMAN LEGUMAIN (AEP) IN COMPLEX WITH COMPOUND 11B
320, p5lu9A_, 0.6800, 2.83, 0.126, 263, 191, CRYSTAL STRUCTURE OF YVAD-CMK BOUND HUMAN LEGUMAIN (AEP) IN COMPLEX WITH COMPOUND 11
321, p5lu8A_, 0.6800, 2.84, 0.126, 261, 191, CRYSTAL STRUCTURE OF YVAD-CMK BOUND HUMAN LEGUMAIN (AEP) IN COMPLEX WITH COMPOUND 11B
322, p4fguA1, 0.6785, 2.82, 0.126, 262, 191, CRYSTAL STRUCTURE OF PROLEGUMAIN
323, p4d3yA1, 0.6783, 2.81, 0.126, 262, 190, THE STRUCTURE OF INACTIVE PROLEGUMAIN FROM CHINESE HAMSTER.
324, p4fguB1, 0.6772, 2.82, 0.132, 287, 190, CRYSTAL STRUCTURE OF PROLEGUMAIN
325, p4d3xA_, 0.6758, 2.84, 0.126, 261, 190, THE STRUCTURE OF MATURE LEGUMAIN FROM CHINESE HAMSTER.
326, d3sirB_, 0.6724, 2.76, 0.143, 283, 189, CRYSTAL STRUCTURE OF DRICE
327, p4afvA_, 0.6699, 2.84, 0.126, 261, 190, THE STRUCTURE OF METACASPASE 2 FROM T. BRUCEI DETERMINED IN THE PRESENCE OF CALCIUM CHLORIDE
328, p4afrA_, 0.6675, 2.76, 0.143, 287, 189, THE STRUCTURE OF METACASPASE 2  (C213A MUTANT)  FROM T. BRUCEI
329, p4af8A_, 0.6662, 2.77, 0.138, 260, 189, THE STRUCTURAL BASIS FOR METACASPASE SUBSTRATE SPECIFICITY AND ACTIVATION
330, p4afpA_, 0.6635, 2.85, 0.126, 261, 190, THE STRUCTURE OF METACASPASE 2 FROM T. BRUCEI DETERMINED IN THE PRESENCE OF SAMARIUM
331, d3sirD_, 0.6556, 2.75, 0.143, 287, 189, CRYSTAL STRUCTURE OF DRICE
332, d3sirC_, 0.6519, 2.86, 0.126, 261, 190, CRYSTAL STRUCTURE OF DRICE
333, p4tkxL1, 0.6119, 2.86, 0.116, 261, 190, STRUCTURE OF PROTEASE
334, d2k7zA_, 0.6108, 2.85, 0.126, 262, 190, SOLUTION STRUCTURE OF THE CATALYTIC DOMAIN OF PROCASPASE-8
335, p4rbmA1, 0.6105, 2.85, 0.126, 262, 190, PORPHYROMONAS GINGIVALIS GINGIPAIN K (KGP) CATALYTIC AND IMMUNOGLOBULIN SUPERFAMILY-LIKE DOMAINS
336, p4jb8A_, 0.5852, 2.81, 0.127, 287, 189, CASPASE-7 IN COMPLEX WITH DARPIN C7_16
337, p3kjfA_, 0.5844, 2.82, 0.127, 294, 189, CASPASE 3 BOUND TO A COVALENT INHIBITOR
338, p5ic6C_, 0.5814, 2.82, 0.127, 294, 189, CRYSTAL STRUCTURE OF CASPASE-7 DEVE PEPTIDE COMPLEX
339, p4zvtC_, 0.5814, 2.82, 0.127, 287, 189, CASPASE-7 VARIANT 1 (V1) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230A/W232M/S234N SUBSTITUTIONS BOUND TO VEID INHIBITOR.
340, p2qljA_, 0.5811, 2.85, 0.127, 259, 189, CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-WEHD-CHO
341, p2ql9A_, 0.5811, 1.94, 0.429, 172, 170, CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-DQMD-CHO
342, p3ibcA_, 0.5810, 1.94, 0.429, 172, 170, CRYSTAL STRUCTURE OF CASPASE-7 INCOMPLEX WITH ACETYL-YVAD- CHO
343, p2ql5A_, 0.5810, 3.38, 0.143, 317, 196, CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-DMQD-CHO
344, p4zvoC_, 0.5809, 3.39, 0.144, 330, 195, CASPASE-7 VARIANT 4 (V4) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230V/W232Y/S234V/Q276D SUBSTITUTIONS BOUND TO VEID INHIBITOR.
345, p2qljC_, 0.5809, 3.40, 0.144, 332, 195, CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-WEHD-CHO
346, p5ic4C_, 0.5808, 3.40, 0.144, 332, 195, CRYSTAL STRUCTURE OF CASPASE-3 DEVE PEPTIDE COMPLEX
347, p4zvuC_, 0.5807, 3.31, 0.145, 325, 193, CASPASE-7 WILD-TYPE BOUND TO THE CASPASE-6 COGNATE TETRAPEPTIDE INHIBITOR AC-VEID-CHO
348, p4zvsC_, 0.5807, 1.18, 0.420, 169, 162, CASPASE-7 VARIANT 1 (V1) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230A/W232M/S234N SUBSTITUTIONS BOUND TO DEVD INHIBITOR.
349, p3ibcC_, 0.5807, 1.32, 0.414, 162, 162, CRYSTAL STRUCTURE OF CASPASE-7 INCOMPLEX WITH ACETYL-YVAD- CHO
350, p2qlbA_, 0.5806, 3.85, 0.105, 253, 191, CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-ESMD-CHO
351, p2ql7A_, 0.5806, 3.78, 0.366, 229, 186, CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-IEPD-CHO
352, p5ic6A_, 0.5805, 4.06, 0.104, 253, 193, CRYSTAL STRUCTURE OF CASPASE-7 DEVE PEPTIDE COMPLEX
353, p5ic4E_, 0.5805, 4.06, 0.104, 253, 193, CRYSTAL STRUCTURE OF CASPASE-3 DEVE PEPTIDE COMPLEX
354, p4zvqC_, 0.5805, 0.89, 0.500, 143, 142, CASPASE-7 VARIANT 2 (V2) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230V/W232M/Q276C SUBSTITUTIONS BOUND TO VEID INHIBITOR.
355, p3ibfA_, 0.5805, 0.28, 0.993, 140, 140, CRYSTAL STRUCTURE OF UNLIGANDED CASPASE-7
356, p2qlfC_, 0.5805, 0.50, 0.507, 140, 140, CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-DNLD-CHO
357, p2ql9C_, 0.5803, 0.50, 0.507, 140, 140, CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-DQMD-CHO
358, p5k20C_, 0.5802, 0.52, 0.507, 140, 140, CASPASE-7 S239E PHOSPHOMIMETIC
359, p4zvpC_, 0.5802, 0.52, 0.507, 140, 140, CASPASE-7 VARIANT 2 (V2) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230V/W232M/Q276C SUBSTITUTIONS BOUND TO DEVD INHIBITOR.
360, p2qlbC_, 0.5802, 0.52, 0.507, 140, 140, CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-ESMD-CHO
361, p2ql7C_, 0.5802, 0.52, 0.507, 140, 140, CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-IEPD-CHO
362, p5k20A_, 0.5800, 0.53, 0.507, 140, 140, CASPASE-7 S239E PHOSPHOMIMETIC
363, p5ic4A_, 0.5799, 0.53, 0.507, 140, 140, CRYSTAL STRUCTURE OF CASPASE-3 DEVE PEPTIDE COMPLEX
364, p2ql5C_, 0.5797, 0.20, 0.993, 139, 139, CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-DMQD-CHO
365, p4zvqA_, 0.5773, 0.54, 0.507, 140, 140, CASPASE-7 VARIANT 2 (V2) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230V/W232M/Q276C SUBSTITUTIONS BOUND TO VEID INHIBITOR.
366, p4zvpA_, 0.5773, 0.54, 0.507, 140, 140, CASPASE-7 VARIANT 2 (V2) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230V/W232M/Q276C SUBSTITUTIONS BOUND TO DEVD INHIBITOR.
367, p4zvtA_, 0.5771, 0.54, 0.507, 140, 140, CASPASE-7 VARIANT 1 (V1) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230A/W232M/S234N SUBSTITUTIONS BOUND TO VEID INHIBITOR.
368, p4zvoA_, 0.5771, 0.54, 0.507, 140, 140, CASPASE-7 VARIANT 4 (V4) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230V/W232Y/S234V/Q276D SUBSTITUTIONS BOUND TO VEID INHIBITOR.
369, p4zvrA_, 0.5769, 0.54, 0.507, 140, 140, CASPASE-7 VARIANT 4 (V4) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230V/W232Y/S234V/Q276D SUBSTITUTIONS BOUND TO DEVD INHIBITOR.
370, p4zvuA_, 0.5768, 0.55, 0.507, 140, 140, CASPASE-7 WILD-TYPE BOUND TO THE CASPASE-6 COGNATE TETRAPEPTIDE INHIBITOR AC-VEID-CHO
371, p4zvsA_, 0.5768, 0.24, 0.993, 139, 139, CASPASE-7 VARIANT 1 (V1) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230A/W232M/S234N SUBSTITUTIONS BOUND TO DEVD INHIBITOR.
372, p3edrA_, 0.5768, 0.55, 0.507, 140, 140, THE CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ACETYL-LDESD-CHO
373, p2qlfA_, 0.5767, 0.55, 0.507, 140, 140, CRYSTAL STRUCTURE OF CASPASE-7 WITH INHIBITOR AC-DNLD-CHO
374, p4zvrC_, 0.5765, 0.55, 0.507, 140, 140, CASPASE-7 VARIANT 4 (V4) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230V/W232Y/S234V/Q276D SUBSTITUTIONS BOUND TO DEVD INHIBITOR.
375, p5obtB_, 0.5613, 0.56, 0.507, 140, 140, FULLY ACTIVATED A. THALIANA LEGUMAIN ISOFORM GAMMA IN COMPLEX WITH AC- YVAD-CMK 
376, p2y1lC_, 0.5609, 0.57, 0.507, 140, 140, CASPASE-8 IN COMPLEX WITH DARPIN-8.4
377, p6bfoA_, 0.5602, 0.57, 0.507, 140, 140, CASPASE-3 MUTANT- T245D
378, p5obtA_, 0.5559, 0.57, 0.507, 140, 140, FULLY ACTIVATED A. THALIANA LEGUMAIN ISOFORM GAMMA IN COMPLEX WITH AC- YVAD-CMK 
379, p3ibfC_, 0.5523, 0.57, 0.507, 140, 140, CRYSTAL STRUCTURE OF UNLIGANDED CASPASE-7
380, p3edrC_, 0.5521, 0.58, 0.507, 140, 140, THE CRYSTAL STRUCTURE OF CASPASE-7 IN COMPLEX WITH ACETYL-LDESD-CHO
381, p6bfkA_, 0.5517, 0.31, 0.993, 139, 139, CASPASE-3 MUTANT- T245A
382, p6bfkB_, 0.5516, 0.59, 0.507, 140, 140, CASPASE-3 MUTANT- T245A
383, p5fc2B4, 0.5510, 0.50, 0.511, 139, 139, STRUCTURE OF A SEPARASE IN COMPLEX WITH A PAMK PEPTIDE CONTAINING A PHOSPHO-SERINE
384, p5fbyA3, 0.5507, 0.49, 0.511, 139, 139, CRYSTAL STRUCTURE OF CTSPD
385, p5fc3B3, 0.5495, 0.51, 0.511, 139, 139, STRUCTURAL BASIS OF COHESIN CLEAVAGE BY SEPARASE
386, p6bg4B_, 0.5477, 0.51, 0.511, 139, 139, CASPASE-3 MUTANT- T152D
387, p6bflA_, 0.5477, 0.52, 0.511, 139, 139, CASPASE-3 MUTANT- D9AD28AT245D
388, p6bdvA_, 0.5474, 0.52, 0.511, 139, 139, CRYSTAL STRUCTURE OF CASPASE 3 S150A
389, p6bg0A_, 0.5473, 0.53, 0.511, 139, 139, CASPASE-3 MUTANT - D9AD28AS150D
390, p3edqC_, 0.5472, 0.52, 0.511, 139, 139, CRYSTAL STRUCTURE OF CASPASE-3 WITH INHIBITOR AC-LDESD-CHO
391, p6bg4A_, 0.5471, 0.53, 0.511, 139, 139, CASPASE-3 MUTANT- T152D
392, p4dcpD_, 0.5471, 0.54, 0.511, 139, 139, CRYSTAL STRUCTURE OF CASPASE 3 L168F MUTANT
393, p4dcjD_, 0.5471, 2.86, 0.096, 229, 157, CRYSTAL STRUCTURE OF CASPASE 3 L168D MUTANT
394, p4dcoD_, 0.5470, 1.33, 0.414, 148, 140, CRYSTAL STRUCTURE OF CASPASE 3 L168Y MUTANT
395, p3gjrC_, 0.5470, 0.15, 0.993, 134, 134, CASPASE-3 BINDS DIVERSE P4 RESIDUES IN PEPTIDES
396, p3gjrA_, 0.5468, 2.82, 0.097, 227, 155, CASPASE-3 BINDS DIVERSE P4 RESIDUES IN PEPTIDES
397, p2xzdC_, 0.5468, 0.50, 0.519, 133, 133, CASPASE-3 IN COMPLEX WITH AN INHIBITORY DARPIN-3.4
398, p3gjqA_, 0.5465, 0.51, 0.519, 133, 133, CASPASE-3 BINDS DIVERSE P4 RESIDUES IN PEPTIDES
399, p6bg0B_, 0.5463, 0.18, 0.992, 132, 132, CASPASE-3 MUTANT - D9AD28AS150D
400, p3gjtA_, 0.5462, 0.20, 0.992, 132, 132, CASPASE-3 BINDS DIVERSE P4 RESIDUES IN PEPTIDES
401, p2h65C_, 0.5462, 4.01, 0.080, 225, 175, CRYSTAL STRUSTURE OF CASPASE-3 WITH INHIBITOR AC-VDVAD-CHO
402, p2xztC_, 0.5461, 4.01, 0.080, 208, 175, CASPASE-3 IN COMPLEX WITH DARPIN-3.4_I78S
403, p2h5jA_, 0.5461, 4.07, 0.080, 260, 175, CRYSTAL STRUSTURE OF CASPASE-3 WITH INHIBITOR AC-DMQD-CHO
404, p3gjsA_, 0.5458, 4.07, 0.080, 260, 175, CASPASE-3 BINDS DIVERSE P4 RESIDUES IN PEPTIDES
405, p4dcpA_, 0.5450, 0.15, 0.992, 131, 131, CRYSTAL STRUCTURE OF CASPASE 3 L168F MUTANT
406, p4dcoA_, 0.5450, 0.14, 1.000, 131, 131, CRYSTAL STRUCTURE OF CASPASE 3 L168Y MUTANT
407, p4dcjA_, 0.5440, 0.20, 0.992, 131, 131, CRYSTAL STRUCTURE OF CASPASE 3 L168D MUTANT
408, p4lszC_, 0.5434, 0.22, 0.992, 131, 131, CASPASE-7 IN COMPLEX WITH DARPIN D7.18
409, p2xzdA_, 0.5431, 0.23, 1.000, 131, 131, CASPASE-3 IN COMPLEX WITH AN INHIBITORY DARPIN-3.4
410, p2y0bA_, 0.5430, 0.24, 0.992, 131, 131, CASPASE-3 IN COMPLEX WITH AN INHIBITORY DARPIN-3.4_S76R
411, p3gjsC_, 0.5429, 0.25, 1.000, 131, 131, CASPASE-3 BINDS DIVERSE P4 RESIDUES IN PEPTIDES
412, p2h5jC_, 0.5428, 0.25, 1.000, 131, 131, CRYSTAL STRUSTURE OF CASPASE-3 WITH INHIBITOR AC-DMQD-CHO
413, p2y0bC_, 0.5426, 0.25, 1.000, 131, 131, CASPASE-3 IN COMPLEX WITH AN INHIBITORY DARPIN-3.4_S76R
414, p2xztA_, 0.5426, 0.25, 1.000, 131, 131, CASPASE-3 IN COMPLEX WITH DARPIN-3.4_I78S
415, p3gjtC_, 0.5415, 0.27, 1.000, 131, 131, CASPASE-3 BINDS DIVERSE P4 RESIDUES IN PEPTIDES
416, p2h65A_, 0.5409, 0.28, 1.000, 131, 131, CRYSTAL STRUSTURE OF CASPASE-3 WITH INHIBITOR AC-VDVAD-CHO
417, p3gjqC_, 0.5405, 0.31, 1.000, 131, 131, CASPASE-3 BINDS DIVERSE P4 RESIDUES IN PEPTIDES
418, p3kjnA_, 0.5400, 0.33, 0.992, 131, 131, CASPASE 8 BOUND TO A COVALENT INHIBITOR
419, p3edqA_, 0.5399, 0.34, 1.000, 131, 131, CRYSTAL STRUCTURE OF CASPASE-3 WITH INHIBITOR AC-LDESD-CHO
420, p4lszA_, 0.5394, 0.34, 1.000, 131, 131, CASPASE-7 IN COMPLEX WITH DARPIN D7.18
421, p3kjqA_, 0.5394, 0.35, 1.000, 131, 131, CASPASE 8 WITH COVALENT INHIBITOR
422, p5ic4G_, 0.5389, 0.35, 1.000, 131, 131, CRYSTAL STRUCTURE OF CASPASE-3 DEVE PEPTIDE COMPLEX
423, p3p4uA_, 0.5383, 0.38, 1.000, 131, 131, CRYSTAL STRUCTURE OF ACTIVE CASPASE-6 IN COMPLEX WITH AC-VEID-CHO INHIBITOR
424, p3p4uC_, 0.5382, 0.45, 1.000, 131, 131, CRYSTAL STRUCTURE OF ACTIVE CASPASE-6 IN COMPLEX WITH AC-VEID-CHO INHIBITOR
425, p3p45M_, 0.5380, 0.44, 1.000, 131, 131, CRYSTAL STRUCTURE OF APO-CASPASE-6 AT PHYSIOLOGICAL PH
426, p3p45A_, 0.5373, 0.51, 1.000, 131, 131, CRYSTAL STRUCTURE OF APO-CASPASE-6 AT PHYSIOLOGICAL PH
427, p3p45I_, 0.5367, 0.54, 0.504, 131, 131, CRYSTAL STRUCTURE OF APO-CASPASE-6 AT PHYSIOLOGICAL PH
428, p3p45K_, 0.5363, 0.21, 1.000, 130, 130, CRYSTAL STRUCTURE OF APO-CASPASE-6 AT PHYSIOLOGICAL PH
429, p3p45E_, 0.5340, 0.23, 1.000, 130, 130, CRYSTAL STRUCTURE OF APO-CASPASE-6 AT PHYSIOLOGICAL PH
430, p3p45G_, 0.5337, 0.24, 1.000, 130, 130, CRYSTAL STRUCTURE OF APO-CASPASE-6 AT PHYSIOLOGICAL PH
431, p3p45C_, 0.5331, 0.26, 1.000, 130, 130, CRYSTAL STRUCTURE OF APO-CASPASE-6 AT PHYSIOLOGICAL PH
432, p3p45O_, 0.5328, 0.28, 1.000, 130, 130, CRYSTAL STRUCTURE OF APO-CASPASE-6 AT PHYSIOLOGICAL PH
433, p2y1lA_, 0.5317, 0.28, 1.000, 130, 130, CASPASE-8 IN COMPLEX WITH DARPIN-8.4
434, p2c2zA_, 0.5316, 0.39, 1.000, 130, 130, CRYSTAL STRUCTURE OF CASPASE-8 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITOR
435, p3rjmC_, 0.5311, 0.44, 1.000, 130, 130, CASPASE2 IN COMPLEX WITH CHDI LIGAND 33C
436, p3r7nC_, 0.5309, 0.47, 1.000, 130, 130, CASPASE-2 BOUND WITH TWO COPIES OF AC-DVAD-CHO
437, p3r6gC_, 0.5308, 1.11, 0.414, 141, 133, CRYSTAL STRUCTURE OF ACTIVE CASPASE-2 BOUND WITH AC-VDVAD-CHO
438, p3r6lC_, 0.5305, 0.51, 1.000, 130, 130, CASPASE-2 T380A BOUND WITH AC-VDVAD-CHO
439, p3r7sA_, 0.5278, 0.53, 0.500, 130, 130, CRYSTAL STRUCTURE OF APO CASPASE2
440, p3r7sC_, 0.5276, 1.14, 0.414, 141, 133, CRYSTAL STRUCTURE OF APO CASPASE2
441, p2p2cA_, 0.5271, 0.21, 1.000, 129, 129, INHIBITION OF CASPASE-2 BY A DESIGNED ANKYRIN REPEAT PROTEIN (DARPIN)
442, p3r7bC_, 0.5269, 1.27, 0.417, 133, 132, CASPASE-2 BOUND TO ONE COPY OF AC-DVAD-CHO
443, p3r5jC_, 0.5269, 1.28, 0.417, 133, 132, CRYSTAL STRUCTURE OF ACTIVE CASPASE-2 BOUND WITH AC-ADVAD-CHO
444, p2cnlA_, 0.5268, 1.26, 0.402, 133, 132, CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE INHIBITORS.
445, p3rjmA_, 0.5267, 1.27, 0.402, 133, 132, CASPASE2 IN COMPLEX WITH CHDI LIGAND 33C
446, p2cdrA_, 0.5267, 1.31, 0.402, 133, 132, CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE INHIBITORS.
447, p2p2cC_, 0.5266, 1.29, 0.402, 133, 132, INHIBITION OF CASPASE-2 BY A DESIGNED ANKYRIN REPEAT PROTEIN (DARPIN)
448, p3sipC_, 0.5265, 1.26, 0.397, 132, 131, CRYSTAL STRUCTURE OF DRICE AND DIAP1-BIR1 COMPLEX
449, p2p2cG_, 0.5238, 1.26, 0.397, 131, 131, INHIBITION OF CASPASE-2 BY A DESIGNED ANKYRIN REPEAT PROTEIN (DARPIN)
450, p2p2cI_, 0.5237, 1.29, 0.397, 132, 131, INHIBITION OF CASPASE-2 BY A DESIGNED ANKYRIN REPEAT PROTEIN (DARPIN)
451, p6bh9B_, 0.5227, 1.31, 0.397, 132, 131, CASPASE-3 MUTANT - T152A
452, p6bh9A_, 0.5227, 1.31, 0.424, 140, 132, CASPASE-3 MUTANT - T152A
453, p6bfjA_, 0.5227, 1.13, 0.412, 139, 131, CASPASE-3 MUTANT - T245DS249D
454, p2dkoA_, 0.5227, 0.93, 0.354, 132, 130, EXTENDED SUBSTRATE RECOGNITION IN CASPASE-3 REVEALED BY HIGH RESOLUTION X-RAY STRUCTURE ANALYSIS
455, p2cjxA_, 0.5227, 0.94, 0.354, 132, 130, EXTENDED SUBSTRATE RECOGNITION IN CASPASE-3 REVEALED BY HIGH RESOLUTION X-RAY STRUCTURE ANALYSIS
456, p6bhaA_, 0.5226, 0.94, 0.354, 132, 130, CASPASE-3 MUTANT - T152V
457, p6bgkA_, 0.5226, 0.95, 0.354, 132, 130, CASPASE-3 MUTANT- D9AD28AT152D
458, p2xypA_, 0.5226, 0.88, 0.357, 131, 129, CASPASE-3:CAS26049945
459, p2cnoA_, 0.5226, 0.89, 0.357, 131, 129, CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE INHIBITORS.
460, p2cnkA_, 0.5226, 1.09, 0.354, 132, 130, CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE INHIBITORS.
461, p2cjyA_, 0.5226, 0.94, 0.357, 131, 129, EXTENDED SUBSTRATE RECOGNITION IN CASPASE-3 REVEALED BY HIGH RESOLUTION X-RAY STRUCTURE ANALYSIS
462, p6bgsA_, 0.5225, 0.94, 0.357, 131, 129, CASPASE-3 MUTANT - S150Y
463, p6bgqA_, 0.5225, 0.14, 1.000, 126, 126, CASPASE-3 MUTANT - S150D
464, p2c2oA_, 0.5225, 0.94, 0.357, 131, 129, CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITORS.
465, p2c2mA_, 0.5225, 0.16, 1.000, 126, 126, CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITORS.
466, p2c2kA_, 0.5225, 1.10, 0.354, 132, 130, CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITORS.
467, p2c1eA_, 0.5225, 0.96, 0.357, 129, 129, CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE MICHAEL ACCEPTOR INHIBITORS.
468, p6bg1A_, 0.5224, 1.06, 0.357, 131, 129, CASPASE-3 MUTANT - D9AD28AS150E
469, p2p2cE_, 0.5223, 1.05, 0.357, 131, 129, INHIBITION OF CASPASE-2 BY A DESIGNED ANKYRIN REPEAT PROTEIN (DARPIN)
470, p2cnnA_, 0.5223, 0.13, 0.992, 125, 125, CRYSTAL STRUCTURES OF CASPASE-3 IN COMPLEX WITH AZA-PEPTIDE EPOXIDE INHIBITORS.
471, p2xyhA_, 0.5222, 0.13, 0.992, 125, 125, CASPASE-3:CAS60254719
472, p2xygA_, 0.5220, 0.13, 1.000, 125, 125, CASPASE-3:CAS329306
473, p2h5iA_, 0.5215, 0.12, 1.000, 125, 125, CRYSTAL STRUCTURE OF CASPASE-3 WITH INHIBITOR AC-DEVD-CHO
474, p2h51A_, 0.5211, 0.13, 1.000, 125, 125, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (GLU390->ASP AND ARG286->LYS) IN COMPLEX WITH 3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)- PROPIONYLAMINO]-4-OXO-PENTANOIC ACID (Z-VAD-FMK)
475, p5mz614, 0.5192, 0.14, 0.992, 125, 125, CRYO-EM STRUCTURE OF A SEPARASE-SECURIN COMPLEX FROM CAENORHABDITIS ELEGANS AT 3.8 A RESOLUTION
476, p3r6gA_, 0.5192, 0.15, 0.992, 125, 125, CRYSTAL STRUCTURE OF ACTIVE CASPASE-2 BOUND WITH AC-VDVAD-CHO
477, p6bgkB_, 0.5184, 0.15, 1.000, 125, 125, CASPASE-3 MUTANT- D9AD28AT152D
478, p6bgqC_, 0.5183, 0.14, 1.000, 125, 125, CASPASE-3 MUTANT - S150D
479, p3sipA_, 0.5182, 0.15, 1.000, 125, 125, CRYSTAL STRUCTURE OF DRICE AND DIAP1-BIR1 COMPLEX
480, p5mmvA_, 0.5181, 0.15, 1.000, 125, 125, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 WITH 2-((2-NAPHTHOYL)-L-VALYL)-4- HYDROXY-N-((3S)-2-HYDROXY-5-OXOTETRAHYDROFURAN-3-YL)-2- AZABICYCLO[2.2.2]OCTANE-3-CARBOXAMIDE (COMPOUND 1)
481, p6bgrA_, 0.5180, 0.17, 0.992, 125, 125, CASPASE-3 MUTANT - S150E
482, p2p2cK_, 0.5180, 0.17, 0.992, 125, 125, INHIBITION OF CASPASE-2 BY A DESIGNED ANKYRIN REPEAT PROTEIN (DARPIN)
483, p3r7bA_, 0.5160, 0.18, 1.000, 125, 125, CASPASE-2 BOUND TO ONE COPY OF AC-DVAD-CHO
484, p3r6lA_, 0.5122, 0.17, 1.000, 125, 125, CASPASE-2 T380A BOUND WITH AC-VDVAD-CHO
485, p2fqqA_, 0.5107, 0.17, 1.000, 125, 125, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (CYS285->ALA CYS362->ALA CYS364->ALA CYS397->ALA) IN COMPLEX WITH 1-METHYL-3-TRIFLUOROMETHYL- 1H-THIENO[23-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE
486, p3r7nA_, 0.5091, 0.18, 1.000, 125, 125, CASPASE-2 BOUND WITH TWO COPIES OF AC-DVAD-CHO
487, p3r5jA_, 0.5090, 0.19, 0.992, 125, 125, CRYSTAL STRUCTURE OF ACTIVE CASPASE-2 BOUND WITH AC-ADVAD-CHO
488, p3d6hA_, 0.5051, 1.10, 0.357, 131, 129, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 WITH A NATURALLY-OCCURRING ASN263->SER SUBSTITUTION IN COMPLEX WITH 3-[2-(2- BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO- PENTANOIC ACID (Z-VAD-FMK)
489, p2hbzA_, 0.5048, 0.21, 1.000, 125, 125, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (ARG286->ALA GLU390->ALA) IN COMPLEX WITH 3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)- PROPIONYLAMINO]-4-OXO-PENTANOIC ACID (Z-VAD-FMK)
490, p2h4yA_, 0.5048, 0.21, 1.000, 125, 125, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (ARG286->LYS) IN COMPLEX WITH 3- [2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]- 4-OXO-PENTANOIC ACID (Z-VAD-FMK)
491, p6bz9A_, 0.5043, 0.25, 1.000, 125, 125, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 IN COMPLEX WITH AC-FLTD-CMK 
492, p2hbyA_, 0.5037, 0.30, 1.000, 125, 125, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (GLU390->ALA) IN COMPLEX WITH 3- [2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]- 4-OXO-PENTANOIC ACID (Z-VAD-FMK)
493, p2h48A_, 0.5036, 1.53, 0.305, 157, 131, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (CYS362->ALA CYS364->ALA CYS397->ALA) IN COMPLEX WITH 3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL- BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID (Z-VAD-FMK)
494, p3d6mA_, 0.5034, 3.80, 0.073, 227, 164, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 WITH A NATURALLY-OCCURRING LYS319->ARG SUBSTITUTION IN COMPLEX WITH 3-[2-(2- BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO- PENTANOIC ACID (Z-VAD-FMK)
495, p2hbqA_, 0.5033, 3.80, 0.073, 227, 164, CRYSTAL STRUCTURE OF WILDTYPE HUMAN CASPASE-1 IN COMPLEX WITH 3-[2-(2- BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO- PENTANOIC ACID (Z-VAD-FMK)
496, p2hbrA_, 0.5032, 0.91, 0.362, 129, 127, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (ARG286->ALA) IN COMPLEX WITH 3- [2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]- 4-OXO-PENTANOIC ACID (Z-VAD-FMK)
497, p2h54A_, 0.5032, 0.15, 0.992, 124, 124, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (THR388->ALA) IN COMPLEX WITH 3- [2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]- 4-OXO-PENTANOIC ACID (Z-VAD-FMK)
498, p2h4wA_, 0.5032, 0.17, 0.992, 124, 124, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 (GLU390->ASP) IN COMPLEX WITH 3- [2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]- 4-OXO-PENTANOIC ACID (Z-VAD-FMK)
499, p3d6fA_, 0.5031, 0.96, 0.354, 127, 127, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 WITH A NATURALLY-OCCURRING ARG240->GLN SUBSTITUTION IN COMPLEX WITH 3-[2-(2- BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO- PENTANOIC ACID (Z-VAD-FMK)
500, p6f6rA_, 0.5030, 1.47, 0.308, 156, 130, CRYSTAL STRUCTURE OF HUMAN CASPASE-1 WITH N-{3-[1-((S)-2-HYDROXY-5- OXO-TETRAHYDRO-FURAN-3-YLCARBAMOYL)-ETHYL]-1-METHYL-2;4-DIOXO-1;2;3; 4-TETRAHYDRO-PYRIMIDIN-5-YL}-4-(QUINOXALIN-2-YLAMINO)-BENZAMIDE 
501, p3ns7A_, 0.5027, 0.22, 0.992, 124, 124, SUCCINIC ACID AMIDES AS P2-P3 REPLACEMENTS FOR INHIBITORS OF INTERLEUKIN-1BETA CONVERTING ENZYME (ICE OR CASPASE 1)
